1-229595051-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_014409.4(TAF5L):c.1016G>A(p.Arg339Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,611,942 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R339W) has been classified as Uncertain significance.
Frequency
Consequence
NM_014409.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF5L | NM_014409.4 | c.1016G>A | p.Arg339Gln | missense_variant | 5/5 | ENST00000258281.7 | NP_055224.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF5L | ENST00000258281.7 | c.1016G>A | p.Arg339Gln | missense_variant | 5/5 | 5 | NM_014409.4 | ENSP00000258281.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152172Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248514Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134342
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1459770Hom.: 0 Cov.: 33 AF XY: 0.00000964 AC XY: 7AN XY: 725842
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152172Hom.: 1 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.1016G>A (p.R339Q) alteration is located in exon 5 (coding exon 4) of the TAF5L gene. This alteration results from a G to A substitution at nucleotide position 1016, causing the arginine (R) at amino acid position 339 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at